Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TWIST: Tenecteplase in Wake-up Ischaemic Stroke
NCT03181360Phase 3Unknown
- Sponsor
- University Hospital of North Norway
- Start
- Jun 2017
- Primary completion
- Dec 2021
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 11
01
Overview
Phase 3, randomised, open-label trial of tenecteplase in ischemic stroke (2 arms), sponsored by University Hospital of North Norway. Primary endpoint: modified Rankin Scale at 3 months. Status: unknown.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03181360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03181360.